PMID- 34037930
OWN - NLM
STAT- MEDLINE
DCOM- 20210609
LR  - 20230524
IS  - 1573-3254 (Electronic)
IS  - 1090-7165 (Print)
IS  - 1090-7165 (Linking)
VI  - 25
IP  - Suppl 1
DP  - 2021 Jul
TI  - Correlates of Engagement in HIV Care Among Transgender Women of Color in the 
      United States of America.
PG  - 3-12
LID - 10.1007/s10461-021-03306-9 [doi]
AB  - HIV prevalence among transgender women of color (TWC) in the United States of 
      America is high. We enrolled TWC living with HIV (N = 858) to evaluate 1nine HIV 
      care interventions. We examined factors associated with four outcomes at 
      enrollment: linkage to care, ever being on antiretroviral treatment, retention in 
      care and viral suppression. The sample was 49% Hispanic/Latino, 42% Black; 
      average age was 37 years; 77% were ever linked to care, 36% were ever on 
      treatment, 22% were retained in care, and 36% were virally suppressed. Current 
      hormone use was significantly associated with linkage, retention, and viral 
      suppression (all aORs > 1.5), providing evidence for gender-affirming care as an 
      important facilitator of engagement in HIV care. Greater health care empowerment 
      was significantly associated with greater odds of all outcomes (aORs between 1.19 
      and 1.37). These findings identify potential intervention targets to improve the 
      provision of care and treatment for TWC living with HIV.
FAU - Sevelius, Jae M
AU  - Sevelius JM
AUID- ORCID: 0000-0002-8318-038X
AD  - Center for AIDS Prevention Studies, Department of Medicine, University of 
      California, UCSF/CAPS, 550 16th Street, 3rd floor, San Francisco, CA, 94158, USA. 
      Jae.Sevelius@ucsf.edu.
AD  - Center of Excellence for Transgender Health, Department of Medicine, University 
      of California, San Francisco, CA, USA. Jae.Sevelius@ucsf.edu.
FAU - Xavier, Jessica
AU  - Xavier J
AD  - Silvery Springs, Washington DC, MD, USA.
FAU - Chakravarty, Deepalika
AU  - Chakravarty D
AD  - Center for AIDS Prevention Studies, Department of Medicine, University of 
      California, UCSF/CAPS, 550 16th Street, 3rd floor, San Francisco, CA, 94158, USA.
FAU - Keatley, JoAnne
AU  - Keatley J
AD  - Innovative Response Globally for Transgender Women and HIV (IRGT), San Francisco, 
      CA, USA.
FAU - Shade, Starley
AU  - Shade S
AD  - Department of Epidemiology & Biostatistics, University of California, San 
      Francisco, CA, USA.
FAU - Rebchook, Greg
AU  - Rebchook G
AD  - Center for AIDS Prevention Studies, Department of Medicine, University of 
      California, UCSF/CAPS, 550 16th Street, 3rd floor, San Francisco, CA, 94158, USA.
AD  - Center of Excellence for Transgender Health, Department of Medicine, University 
      of California, San Francisco, CA, USA.
CN  - SPNS Transgender Women of Color Study Group
LA  - eng
GR  - K24 DA051328/DA/NIDA NIH HHS/United States
GR  - U90HA24973/HRSA/HRSA HHS/United States
PT  - Journal Article
DEP - 20210526
PL  - United States
TA  - AIDS Behav
JT  - AIDS and behavior
JID - 9712133
RN  - 0 (Anti-Retroviral Agents)
SB  - IM
MH  - Adult
MH  - Anti-Retroviral Agents/therapeutic use
MH  - Continuity of Patient Care
MH  - Female
MH  - *HIV Infections/drug therapy/epidemiology
MH  - Humans
MH  - Skin Pigmentation
MH  - *Transgender Persons
MH  - United States/epidemiology
PMC - PMC10204129
MID - NIHMS1901183
OTO - NOTNLM
OT  - Engagement in care
OT  - HIV
OT  - HIV care continuum
OT  - HIV treatment
OT  - Transgender women
COIS- Conflict of interest None to disclose.
EDAT- 2021/05/27 06:00
MHDA- 2021/06/10 06:00
PMCR- 2023/05/23
CRDT- 2021/05/26 12:41
PHST- 2021/05/09 00:00 [accepted]
PHST- 2021/05/27 06:00 [pubmed]
PHST- 2021/06/10 06:00 [medline]
PHST- 2021/05/26 12:41 [entrez]
PHST- 2023/05/23 00:00 [pmc-release]
AID - 10.1007/s10461-021-03306-9 [pii]
AID - 10.1007/s10461-021-03306-9 [doi]
PST - ppublish
SO  - AIDS Behav. 2021 Jul;25(Suppl 1):3-12. doi: 10.1007/s10461-021-03306-9. Epub 2021 
      May 26.